Sorrento Therapeutics Shanghai Co., Ltd., a subsidiary of Sorrento Therapeutics, Inc., is a prominent player in the biopharmaceutical industry, headquartered in the United States. Established in 2006, the company has made significant strides in the development of innovative therapies, particularly in oncology and immunology. With major operations in Shanghai, Sorrento Therapeutics focuses on advancing its proprietary antibody and cell therapy platforms, which are designed to address unmet medical needs. The company is renowned for its unique approach to drug development, leveraging cutting-edge technologies to create targeted therapies. Sorrento Therapeutics has achieved notable milestones, including successful clinical trials and strategic partnerships that enhance its market position. As a leader in the biopharmaceutical sector, Sorrento Therapeutics continues to push the boundaries of science, aiming to deliver transformative treatments to patients worldwide.
We don't have data for Sorrento Therapeutics Shanghai Co., Ltd., but we can show you information about their parent organization instead.
View parent company